Caspofungin: Difference between revisions

Line 25: Line 25:
==Adverse Reactions==
==Adverse Reactions==
===Serious===
===Serious===
*Erythema multiforme, Stevens-Johnson syndrome
*[[Erythema multiforme]], [[Stevens-Johnson syndrome]]
*Pancreatitis, hepatic failure
*[[Pancreatitis]], [[hepatic failure]]
*Sepsis
*[[Sepsis]]
*Nephrotoxicity
*[[Nephrotoxicity]]
*Pleural effusion, respiratory distress
*[[Pleural effusion]], respiratory distress
*Angioedema
*[[Angioedema]]
 
===Common===
===Common===
*Hypotension
*[[Hypotension]]
*Rash
*[[Rash]]
*Diarrhea
*[[Diarrhea]]
*Histaminergic reaction (flushing, warmth, pruritus)
*[[Histaminergic reaction]] (flushing, warmth, pruritus)
*Transaminitis
*[[Transaminitis]]
*Fever
*[[Fever]]


==Pharmacology==
==Pharmacology==

Revision as of 06:15, 8 September 2016

Administration

Adult Dosing

  • 50-150 mg IV daily

Pediatric Dosing

3 months or older

  • 50-70 mg/m(2) daily

Special Populations

Renal Dosing

  • Adult:
  • Pediatric:

Hepatic Dosing

  • Adult:
  • Pediatric:

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life: 13-15 hours
  • Metabolism: spontaneous degradation, hydrolysis and N-acetylation
  • Excretion: Fecal, renal

Mechanism of Action

  • Inhibits beta (1,3)-D-glucan synthesis in fungal cell wall

Comments

See Also

References